Bessemer Group
GSK icon

Bessemer Group’s GSK GSK Stock Holding History

Bessemer Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$779K Buy
14,855
+293
+2% +$15.5K ﹤0.01% 1056
2026
Q1 		$804K Buy
14,562
+704
+5% +$38.1K ﹤0.01% 996
2025
Q4 		$680K Sell
13,858
-143
-1% -$6.67K ﹤0.01% 1056
2025
Q3 		$604K Buy
14,001
+730
+6% +$28.5K ﹤0.01% 791
2025
Q2 		$510K Sell
13,271
-1,109
-8% -$42.4K ﹤0.01% 806
2025
Q1 		$556K Buy
14,380
+120
+0.8% +$4.39K ﹤0.01% 841
2024
Q4 		$481K Sell
14,260
-29,726
-68% -$1.07M ﹤0.01% 890
2024
Q3 		$1.8M Sell
43,986
-44
-0.1% -$1.8K ﹤0.01% 675
2024
Q2 		$1.7M Sell
44,030
-1,372
-3% -$57.7K ﹤0.01% 543
2024
Q1 		$1.95M Sell
45,402
-3,971
-8% -$164K ﹤0.01% 530
2023
Q4 		$1.83M Buy
49,373
+7,351
+17% +$264K ﹤0.01% 502
2023
Q3 		$1.52M Sell
42,022
-2,102
-5% -$74.6K ﹤0.01% 527
2023
Q2 		$1.57M Buy
44,124
+31,537
+251% +$1.13M ﹤0.01% 534
2023
Q1 		$448K Sell
12,587
-2,142
-15% -$74.9K ﹤0.01% 751
2022
Q4 		$519K Sell
14,729
-2,413
-14% -$80.4K ﹤0.01% 721
2022
Q3 		$505K Buy
17,142
+5,751
+50% +$218K ﹤0.01% 722
2022
Q2 		$620K Buy
11,391
+213
+2% +$11.8K ﹤0.01% 659
2022
Q1 		$608K Sell
11,178
-1,032
-8% -$56.1K ﹤0.01% 586
2021
Q4 		$674K Buy
12,210
+824
+7% +$42.9K ﹤0.01% 552
2021
Q3 		$544K Sell
11,386
-206
-2% -$10.3K ﹤0.01% 548
2021
Q2 		$577K Buy
11,592
+1,586
+16% +$76.2K ﹤0.01% 532
2021
Q1 		$446K Sell
10,006
-744
-7% -$33.8K ﹤0.01% 570
2020
Q4 		$495K Buy
10,750
+75
+0.7% +$3.44K ﹤0.01% 533
2020
Q3 		$502K Hold
10,675
– – ﹤0.01% 503
2020
Q2 		$545K Buy
10,675
+217
+2% +$11.1K ﹤0.01% 943
2020
Q1 		$495K Sell
10,458
-1,415
-12% -$75.5K ﹤0.01% 784
2019
Q4 		$697K Sell
11,873
-980
-8% -$54.5K ﹤0.01% 835
2019
Q3 		$684K Buy
12,853
+96
+0.8% +$4.94K ﹤0.01% 792
2019
Q2 		$638K Sell
12,757
-721
-5% -$36.2K ﹤0.01% 816
2019
Q1 		$705K Sell
13,478
-2,091
-13% -$104K ﹤0.01% 722
2018
Q4 		$743K Buy
15,569
+332
+2% +$16.4K ﹤0.01% 646
2018
Q3 		$765K Buy
15,237
+432
+3% +$21.9K ﹤0.01% 647
2018
Q2 		$746K Buy
14,805
+1,723
+13% +$86.8K ﹤0.01% 650
2018
Q1 		$640K Sell
13,082
-279
-2% -$13K ﹤0.01% 704
2017
Q4 		$592K Sell
13,361
-4,890
-27% -$226K ﹤0.01% 760
2017
Q3 		$926K Sell
18,251
-4,736
-21% -$240K ﹤0.01% 680
2017
Q2 		$1.24M Buy
22,987
+4,285
+23% +$228K 0.01% 604
2017
Q1 		$986K Sell
18,702
-3,526
-16% -$179K ﹤0.01% 712
2016
Q4 		$1.07M Sell
22,228
-8,058
-27% -$398K ﹤0.01% 689
2016
Q3 		$1.63M Sell
30,286
-13,131
-30% -$720K 0.01% 495
2016
Q2 		$2.35M Buy
43,417
+1,145
+3% +$60.3K 0.01% 368
2016
Q1 		$2.14M Buy
42,272
+115
+0.3% +$5.73K 0.01% 380
2015
Q4 		$2.13M Buy
42,157
+20,108
+91% +$1.02M 0.01% 417
2015
Q3 		$1.06M Sell
22,049
-1,857
-8% -$96.7K 0.01% 568
2015
Q2 		$1.24M Buy
23,906
+1,610
+7% +$90.7K 0.01% 511
2015
Q1 		$1.29M Sell
22,296
-517
-2% -$29.6K 0.01% 482
2014
Q4 		$1.22M Sell
22,813
-789
-3% -$44.1K 0.01% 448
2014
Q3 		$1.36M Sell
23,602
-582
-2% -$35.7K 0.01% 423
2014
Q2 		$1.62M Sell
24,184
-238
-1% -$16.1K 0.01% 386
2014
Q1 		$1.63M Sell
24,422
-745
-3% -$50.4K 0.01% 373
2013
Q4 		$1.68M Buy
25,167
+311
+1% +$20.2K 0.01% 376
2013
Q3 		$1.56M Buy
24,856
+160
+0.6% +$10.3K 0.01% 355
2013
Q2 		$1.54M Buy
+24,696
New +$1.57M 0.01% 332

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bessemer Group's GSK Position: Q2 2026 in Review

Bessemer Group increased its GSK (GSK) stake by 2% in Q2 2026, buying an estimated $15.5K and bringing the position to 14,855 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

Bessemer Group first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.35M in Q2 2016. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Bessemer Group held 14,855 shares of GSK worth $779K as of Q2 2026.
  • Bessemer Group bought 293 GSK shares in Q2 2026, an estimated $15.5K.
  • GSK made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1056 holding.
  • Bessemer Group first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • Bessemer Group's GSK position peaked at $2.35M in Q2 2016.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.